Status:
COMPLETED
MK0524 Asthma POC Study (0524-008)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Asthma
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of the study is to demonstrate the benefit of MK0524 compared to placebo in patients with chronic asthma.
Eligibility Criteria
Inclusion
- Has symptoms of chronic asthma (shortness of breath, wheezing, chest tightness, etc.) for at least 1 year
- Nonsmoker for at least 1 year with a smoking history of no more than 7 pack-years (i.e., 1 pack per day for 7 years)
Exclusion
- Any clinically significant disease of heart, intestinal, kidney, liver, lung or uncontrolled blood pressure
- Any surgery within 4 weeks prior to Visit 1
- Patient is intending to move or vacation for more than 5 days during the study
- Patient is pregnant or breast-feeding
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2005
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00783601
Start Date
October 1 2004
End Date
May 1 2005
Last Update
October 16 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.